Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.8K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.8K
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.6K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection.

European urology·2024
Same author

Successful completion of large, low-cost randomized cancer trials at an academic cancer center.

Clinical trials (London, England)·2024
Same author

Testosterone Therapy in Men After Radical Prostatectomy for Low-Intermediate Organ-Confined Prostate Cancer.

The Journal of urology·2024
Same author

Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic Risk.

European urology·2024
Same author

Transperineal vs Transrectal Prostate Biopsy-The PREVENT Randomized Clinical Trial.

JAMA oncology·2024
Same author

Clinical utility of an artificial intelligence radiomics-based tool for risk stratification of pulmonary nodules.

JNCI cancer spectrum·2024

Related Experiment Video

Updated: Dec 4, 2025

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

909

Screening for Prostate Cancer.

Sigrid V Carlsson1, Andrew J Vickers2

  • 1Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

The Medical Clinics of North America
|October 25, 2020
PubMed
Summary
This summary is machine-generated.

This article reviews prostate cancer early detection using prostate-specific antigen (PSA) screening, discussing risks, guidelines, and new tools like MRI. It offers primary care physicians practice points and a shared decision-making guide.

Keywords:
BiomarkersMagnetic resonance imagingProstate cancerProstate-specific antigenScreening

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

401
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

944

Related Experiment Videos

Last Updated: Dec 4, 2025

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

909
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

401
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

944

Area of Science:

  • Urology
  • Oncology
  • Public Health

Background:

  • Prostate cancer represents a significant global public health concern.
  • Understanding risk factors is crucial for effective screening strategies.

Purpose of the Study:

  • To provide an evidence-based overview of prostate cancer early detection.
  • To summarize current guideline recommendations for prostate-specific antigen (PSA) screening.
  • To discuss emerging screening tools and decision-making aids.

Main Methods:

  • Review of current evidence on PSA screening for prostate cancer.
  • Analysis of global public health data and risk factors.
  • Discussion of novel biomarkers and Magnetic Resonance Imaging (MRI) in screening.
  • Synthesis of guideline group recommendations.

Main Results:

  • The evidence for PSA screening is multifaceted, with varying recommendations.
  • Novel biomarkers and MRI show promise in improving screening accuracy.
  • Effective shared decision-making is key for patient-centered care.

Conclusions:

  • Primary care physicians require clear guidance on prostate cancer screening.
  • Integrating new tools and shared decision-making can optimize early detection.
  • Evidence-based practice points are essential for managing prostate cancer screening.